Abstract

Candida albicans is a normal microbiota in humans. However, the imbalance and increasing number of C. albicans can cause infections in the vagina, mouth, esophagus, and nails. Sap-3 plays role in the infections especially in the adhesion process, and can used as a therapeutic target for C.albicans. Here an attempt has been made to analyze the potential of the active compounds from noni (Morinda citrifolia) as an antifungal by molecular docking towards Sap-3 protein. Drug-likeness characteristics were analyzed based on the Lipinski Rule of Five. Validation of molecular docking of Sap-3 protein-native ligand was conducted followed by molecular docking of the Sap3 protein-test based on the Lamarckian Genetics Algorithm. The highest binding energy is Beta-sitosterol (-8.77 kcal/mol), followed by Alizarin (-6.47 kcal/mol), Morindone (-6.51 kcal/mol), Quercetin (-5.76 kcal/mol), Pepstatin A (-5.55 kcal/mol), Scopoletin (-5.26 kcal/mol), Kaempferol (-5.13 kcal/mol). Bioactive compounds from noni (Morinda citrifolia) can be an appropriate choice as antifungal and for further experiments through in vitro and in vivo tests.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call